These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26113531)

  • 21. EBF1 is essential for B-lineage priming and establishment of a transcription factor network in common lymphoid progenitors.
    Zandi S; Mansson R; Tsapogas P; Zetterblad J; Bryder D; Sigvardsson M
    J Immunol; 2008 Sep; 181(5):3364-72. PubMed ID: 18714008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
    Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
    Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms.
    Li L; Zhang D; Cao X
    Front Immunol; 2024; 15():1320689. PubMed ID: 38318177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal conversion of B lymphoid leukemia reveals cross-lineage transfer of malignant states.
    Somasundaram R; Åhsberg J; Okuyama K; Ungerbäck J; Lilljebjörn H; Fioretos T; Strid T; Sigvardsson M
    Genes Dev; 2016 Nov; 30(22):2486-2499. PubMed ID: 27913602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
    Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
    Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.
    Okuyama K; Strid T; Kuruvilla J; Somasundaram R; Cristobal S; Smith E; Prasad M; Fioretos T; Lilljebjörn H; Soneji S; Lang S; Ungerbäck J; Sigvardsson M
    PLoS Genet; 2019 Aug; 15(8):e1008280. PubMed ID: 31381561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
    Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility.
    Martín-Lorenzo A; Hauer J; Vicente-Dueñas C; Auer F; González-Herrero I; García-Ramírez I; Ginzel S; Thiele R; Constantinescu SN; Bartenhagen C; Dugas M; Gombert M; Schäfer D; Blanco O; Mayado A; Orfao A; Alonso-López D; Rivas Jde L; Cobaleda C; García-Cenador MB; García-Criado FJ; Sánchez-García I; Borkhardt A
    Cancer Discov; 2015 Dec; 5(12):1328-43. PubMed ID: 26408659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
    Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
    Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.
    Decker T; Pasca di Magliano M; McManus S; Sun Q; Bonifer C; Tagoh H; Busslinger M
    Immunity; 2009 Apr; 30(4):508-20. PubMed ID: 19345119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
    Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
    Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
    Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
    Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.
    Somasundaram R; Prasad MA; Ungerbäck J; Sigvardsson M
    Blood; 2015 Jul; 126(2):144-52. PubMed ID: 25990863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAX5 biallelic genomic alterations define a novel subgroup of B-cell precursor acute lymphoblastic leukemia.
    Bastian L; Schroeder MP; Eckert C; Schlee C; Tanchez JO; Kämpf S; Wagner DL; Schulze V; Isaakidis K; Lázaro-Navarro J; Hänzelmann S; James AR; Ekici A; Burmeister T; Schwartz S; Schrappe M; Horstmann M; Vosberg S; Krebs S; Blum H; Hecht J; Greif PA; Rieger MA; Brüggemann M; Gökbuget N; Neumann M; Baldus CD
    Leukemia; 2019 Aug; 33(8):1895-1909. PubMed ID: 30842609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B Lymphocyte Specification Is Preceded by Extensive Epigenetic Priming in Multipotent Progenitors.
    Strid T; Okuyama K; Tingvall-Gustafsson J; Kuruvilla J; Jensen CT; Lang S; Prasad M; Somasundaram R; Åhsberg J; Cristobal S; Soneji S; Ungerbäck J; Sigvardsson M
    J Immunol; 2021 Jun; 206(11):2700-2713. PubMed ID: 34021049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-cell identity as a metabolic barrier against malignant transformation.
    Chan LN; Müschen M
    Exp Hematol; 2017 Sep; 53():1-6. PubMed ID: 28655536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.
    Kong NR; Davis M; Chai L; Winoto A; Tjian R
    PLoS Genet; 2016 Feb; 12(2):e1005845. PubMed ID: 26900922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional control of pre-B cell development and leukemia prevention.
    Pang SH; Carotta S; Nutt SL
    Curr Top Microbiol Immunol; 2014; 381():189-213. PubMed ID: 24831348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.